Search Results for: CTNNB1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
FHL2 four and a half LIM domains 2
  • PPARA activates gene expression
FOXO1 forkhead box O1
  • AKT phosphorylates targets in the nucleus
  • Regulation of gene expression in beta cells
  • AKT-mediated inactivation of FOXO1A
  • Constitutive Signaling by AKT1 E17K in Cancer
  • MAPK6/MAPK4 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Regulation of localization of FOXO transcription factors
  • FOXO-mediated transcription of cell death genes
  • FOXO-mediated transcription of cell death genes
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Regulation of FOXO transcriptional activity by acetylation
  • Regulation of FOXO transcriptional activity by acetylation
  • FOXO-mediated transcription of cell cycle genes
  • FOXO-mediated transcription of cell cycle genes
  • Alveolar rhabdomyosarcoma
FOXO4 forkhead box O4
  • AKT phosphorylates targets in the nucleus
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Ub-specific processing proteases
  • Regulation of localization of FOXO transcription factors
  • FOXO-mediated transcription of cell death genes
  • FOXO-mediated transcription of cell death genes
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Regulation of FOXO transcriptional activity by acetylation
  • FOXO-mediated transcription of cell cycle genes
  • FOXO-mediated transcription of cell cycle genes
FSCN1 fascin actin-bundling protein 1
  • Interleukin-4 and Interleukin-13 signaling
FUS FUS RNA binding protein
  • mRNA Splicing - Major Pathway
  • Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
  • Myxoid liposarcoma
GLIS2 GLIS family zinc finger 2
  • Nephronophthisis-medullary cystic kidney disease, including; Nephronophthisis (NPH) ; Nephronophthisis-like nephropathy 1; Medullary cystic kidney disease 1; Medullary cystic kidney disease 2 (MSKD2)
GNA13 G protein subunit alpha 13
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • G alpha (12/13) signalling events
  • Thromboxane signalling through TP receptor
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Thrombin signalling through proteinase activated receptors (PARs)
H1-2 H1.2 linker histone, cluster member
  • Apoptosis induced DNA fragmentation
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
HUWE1 HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1
  • Neutrophil degranulation
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Syndromic X-linked mental retardation, including: Turner type (MRXST); Siderius type (MRXSSD) ; Cabezas type (MRXC); Raymond type (MRXSR); Type10 (MRXS10); Type14 (MRXS14); Mental retardation with isolated growth hormone deficiency (MRGH)
IGF2BP1 insulin like growth factor 2 mRNA binding protein 1
  • Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
  • MAPK6/MAPK4 signaling
JADE1 jade family PHD finger 1
  • HATs acetylate histones
KMT2A lysine methyltransferase 2A
  • PKMTs methylate histone lysines
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Transcriptional regulation of granulopoiesis
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
KMT2D lysine methyltransferase 2D
  • Formation of the beta-catenin:TCF transactivating complex
  • PKMTs methylate histone lysines
  • Deactivation of the beta-catenin transactivating complex
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • Kabuki syndrome
LATS2 large tumor suppressor kinase 2
  • Signaling by Hippo
LEO1 LEO1 homolog, Paf1/RNA polymerase II complex component
  • Formation of RNA Pol II elongation complex
  • Formation of the beta-catenin:TCF transactivating complex
  • RNA Polymerase II Pre-transcription Events
  • RNA Polymerase II Transcription Elongation
  • E3 ubiquitin ligases ubiquitinate target proteins
MAGI1 membrane associated guanylate kinase, WW and PDZ domain containing 1
MAGI2 membrane associated guanylate kinase, WW and PDZ domain containing 2
  • Nephrin family interactions
MEN1 menin 1
  • Formation of the beta-catenin:TCF transactivating complex
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Deactivation of the beta-catenin transactivating complex
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • RHO GTPases activate IQGAPs
  • Post-translational protein phosphorylation
  • Carcinoid
  • Adrenal carcinoma
  • Primary hyperparathyroidism; Familial hyperparathyroidism (HRPT)
  • Malignant islet cell carcinoma
MITF melanocyte inducing transcription factor
  • SUMOylation of transcription factors
  • Ocular albinism; Ocular albinism, type I (OA1); Waardenburg syndrome, type II (WS2-OA)
  • Waardenburg syndrome (WS)
  • Malignant melanoma
NDRG1 N-myc downstream regulated 1
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy

Page 7 out of 10 pages